Platform Start-Up Anaphore And Mitsubishi Tanabe Ink Deal For Autoimmune Therapies

Anaphore, Inc., a La Jolla, CA, start-up with a novel platform for developing trimeric proteins called Atrimers, has partnered with Mitsubishi Tanabe Pharma Corporation to work on autoimmune diseases

More from Archive

More from Scrip